A case of solitary lymph node recurrence 9 years after initial treatment for advanced premenopausal endometrioid endometrial cancer; clinical usefulness of hormonal replacement therapy-Reference-Cited by-同舟云学术

A case of solitary lymph node recurrence 9 years after initial treatment for advanced premenopausal endometrioid endometrial cancer; clinical usefulness of hormonal replacement therapy

Published:2023-03-10 Issue:3 Volume:12 Page:168-172
ISSN:2192-3183
Container-title:International Cancer Conference Journal
language:en
Short-container-title:Int Canc Conf J

Author:

Ono Maaya,Yamanoi Koji^ORCID,Okunomiya Asuka,Sagae Yusuke,Okamoto Haruko,Sunada Masumi,Taki Mana,Ukita Masayo,Chigusa Yoshitsugu,Horie Akihito,Yamaguchi Ken,Hamanishi Junzo,Mandai Masaki

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://link.springer.com/content/pdf/10.1007/s13691-023-00599-6.pdf

Reference15 articles.

1. Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7–34. https://doi.org/10.3322/caac.21551

2. Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, Burke TW, Lu KH (2005) Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol 105(3):575–580. https://doi.org/10.1097/01.AOG.0000154151.14516.f7

3. Brennan A, Hickey M (2022) The use of menopausal hormone therapy after cancer. Best Pract Res Clin Obstet Gynaecol 81:22–30. https://doi.org/10.1016/j.bpobgyn.2021.11.005

4. Yokoyama Y, Ito K, Takamatsu K, Takehara K, Nakanishi T, Harano K, Watari H, Susumu N, Aoki D, Saito T, Disease Committee of Uterine Cancer JGOG (2015) How do Japanese gynecologists view hormone replacement therapy for survivors of endometrial cancer? Japanese Gynecologic Oncology Group (JGOG) survey. Int J Clin Oncol 20(5):997–1004. https://doi.org/10.1007/s10147-015-0808-5

5. Barakat RR, Bundy BN, Spirtos NM, Bell J, Mannel RS, Gynecologic Oncology Group Study (2006) Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study. J Clin Oncol 24(4):587–592. https://doi.org/10.1200/JCO.2005.02.8464